항생제
Tigecycline

Tigecycline

제한된

Medium
N/A

Spectrum Of Activity

General Information

Reserved for highly resistant infections or when significant allergies restrict other options and when there is documented susceptibility.

Black Box Warning: Associated with more treatment failures than alternatives and excess mortality. Tigecycline should be reserved for use in situations when alternative treatments are not suitable.

Perform bacteriological examination and sensitivity testing during initiation and for suspected relapse.

Monitor hepatic function for patients with abnormal liver function test, and severe hepatic impairment.

Obtain baseline blood coagulation panel, including fibrinogen, and monitor regularly during treatment.

Common

  • Abdominal pain
  • Diarrhea
  • Nausea
  • Vomiting
  • Headache

Serious

  • Septic shock
  • Acute pancreatitis
  • Clostridioides difficile infection
  • Increased liver enzymes
  • Hyperbilirubinemia
  • Liver failure
  • Pseudotumor cerebri
  • Sepsis
  • Anaphylaxis

Contraindications:

  • Acitretin - may result in increased risk of pseudotumor cerebri

Precautions:

  • Penicillins
  • Retinoids
  • Cholera vaccine, live
  • Oral contraceptives

Antimicrobial class: Tetracycline derivative, Glycylcycline

Pregnancy category: D

Average serum half life: 42 hours

Biliary penetration: Therapeutic

Lung penetration: Therapeutic

Requires Infectious Disease consultation.

Documented safety concerns in bacteremia especially.